aap: Q1 - 40% Sales Growth, EUR730K Operating Income


aap Implantate AG, a medical technology company active in the fields of biomaterials and implants for trauma and joint reconstruction, boosted sales by 40% to EUR 4.4 million in the first quarter of financial year 2006 (previous year: EUR 3.1 million).

For the first quarter the aap Group posted EUR 1.1 million in EBITDA (previous year: EUR337K). The Group’s operating performance or EBIT improved to EUR730K (previous year: EUR6K). EBT totaled EUR708K, or well above the previous year’s EUR minus 39K. After depreciation of capitalized accumulated deficit the surplus for the reporting period amounted to EUR397K (previous year: EUR minus 65K).

The equity ratio for a EUR 25.2 million balance sheet total was 81%.

This result and the development of the second quarter at comparable level lay the groundwork to reconfirm the Management Board’s plans for sales growth in excess of 25% and double-digit EBIT and EBT margins in financial year 2006.